Compounds to treat cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Cell Line Breast Prostate HCT116 Cells HT29 Cells MCF-7 Cells Cells, Cultured

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases44

Neoplasms Breast Neoplasms Neovascularization, Pathologic Prostatic Neoplasms Ovarian Neoplasms Lung Neoplasms Colonic Neoplasms Stomach Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma Carcinoma, Squamous Cell Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Disease Progression Colorectal Neoplasms Rectal Neoplasms Neoplasm Recurrence, Local Cell Transformation, Neoplastic Endometrial Neoplasms Esophageal Neoplasms Liver Neoplasms Adenocarcinoma Disease Models, Animal Neoplasms, Hormone-Dependent Mouth Neoplasms Head and Neck Neoplasms Carcinoma, Small Cell Neoplasms, Radiation-Induced Skin Neoplasms Bone Neoplasms Neoplasms, Second Primary Neoplasms, Glandular and Epithelial Precancerous Conditions Genital Neoplasms, Female Gastrointestinal Neoplasms Mammary Neoplasms, Experimental Thyroid Neoplasms Melanoma Neoplasms, Experimental Pharyngeal Neoplasms

Chemicals and Drugs69

Antineoplastic Agents Antibodies, Monoclonal Cancer Vaccines Neoplasm Proteins Plant Extracts RNA, Messenger Receptors, Estrogen Sulfur Compounds Volatile Organic Compounds Tumor Markers, Biological Receptor, erbB-2 Antineoplastic Agents, Phytogenic RNA, Small Interfering DNA, Neoplasm Prostate-Specific Antigen Tumor Suppressor Protein p53 Tamoxifen Anticarcinogenic Agents Cisplatin Enzyme Inhibitors Fluorouracil Small Molecule Libraries Phenols Heterocyclic Compounds Receptors, Progesterone Antineoplastic Agents, Hormonal Antigens, Neoplasm Biphenyl Compounds Paclitaxel Carcinogens Receptor, Epidermal Growth Factor Aniline Compounds MicroRNAs Tumor Suppressor Proteins Sulfhydryl Compounds Protein Kinase Inhibitors DNA-Binding Proteins Organoselenium Compounds Receptors, Androgen Organometallic Compounds Deoxycytidine Transcription Factors Antimetabolites, Antineoplastic Spiro Compounds Indoles Organotin Compounds Estrogens Organoplatinum Compounds Triterpenes Antibiotics, Antineoplastic Androgens Taxoids RNA, Neoplasm Nitrogen Compounds Proto-Oncogene Proteins c-akt Antibodies, Monoclonal, Humanized Proto-Oncogene Proteins Nuclear Proteins Nitroso Compounds Antioxidants Organophosphorus Compounds BRCA2 Protein Quinazolines Estrogen Receptor alpha Thiazoles Epoxy Compounds DNA Primers Androgen Antagonists BRCA1 Protein

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Immunotherapy Drug Design Genetic Therapy Early Detection of Cancer Survival Analysis Drug Screening Assays, Antitumor Survival Rate Prognosis Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies Xenograft Model Antitumor Assays Gene Expression Profiling Risk Prospective Studies Drug Evaluation, Preclinical Registries Risk Assessment Blotting, Western Inhibitory Concentration 50 Neoplasm Staging Neoplasm Transplantation Combined Modality Therapy Disease-Free Survival Odds Ratio Sensitivity and Specificity Transplantation, Heterologous Chemotherapy, Adjuvant Clinical Trials as Topic Treatment Outcome Models, Biological Risk Factors Oligonucleotide Array Sequence Analysis Reproducibility of Results Molecular Targeted Therapy Magnetic Resonance Spectroscopy Questionnaires Polymerase Chain Reaction Tumor Burden Multivariate Analysis Transfection Kaplan-Meier Estimate Mammography Chromatography, High Pressure Liquid Disease Models, Animal SEER Program Predictive Value of Tests Logistic Models Flow Cytometry Drug Administration Schedule Drug Delivery Systems Drug Discovery Radiotherapy Neoplasm Grading Confidence Intervals Gene Knockdown Techniques Mammary Neoplasms, Experimental Tissue Array Analysis Incidence High-Throughput Screening Assays Phytotherapy Mass Spectrometry Immunoenzyme Techniques DNA Mutational Analysis Palliative Care Administration, Oral Neoplasms, Experimental Biopsy Immunohistochemistry Gas Chromatography-Mass Spectrometry

Psychiatry and Psychology1

Phenomena and Processes50

Apoptosis Signal Transduction Cell Proliferation Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Mutation Drug Resistance, Neoplasm Genetic Predisposition to Disease Molecular Structure Cell Survival Risk Inhibitory Concentration 50 Structure-Activity Relationship Odds Ratio Sensitivity and Specificity Cell Division DNA Methylation Genotype Down-Regulation Cell Cycle Cell Movement Transfection Genes, BRCA1 Promoter Regions, Genetic Base Sequence Polymorphism, Genetic Time Factors Cell Growth Processes Drug Synergism Up-Regulation RNA Interference Phenotype Gene Silencing Diet Phosphorylation Gene Expression Protein Binding Genes, Tumor Suppressor Germ-Line Mutation Genes, Neoplasm Stereoisomerism Kinetics Genes, p53 Postmenopause Alleles Genes, BRCA2 Amino Acid Sequence DNA Damage Transcription, Genetic Heterozygote

Disciplines and Occupations4

Drug Design Medical Oncology Drug Discovery Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Molecular Sequence Data Questionnaires Base Sequence SEER Program Incidence Amino Acid Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care27

Survival Analysis Survival Rate Follow-Up Studies Retrospective Studies Risk National Cancer Institute (U.S.)Prospective Studies Registries Risk Assessment Disease-Free Survival Odds Ratio Sensitivity and Specificity Age Factors Clinical Trials as Topic Treatment Outcome Risk Factors Reproducibility of Results Questionnaires Multivariate Analysis Kaplan-Meier Estimate SEER Program Predictive Value of Tests Logistic Models American Cancer Society Confidence Intervals Incidence Palliative Care

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Neoplasms Antineoplastic Agents Cell Line, Tumor Immunotherapy Drug Design Mice, Nude Breast Neoplasms Apoptosis Signal Transduction Genetic Therapy Neovascularization, Pathologic Cell Proliferation Antibodies, Monoclonal Early Detection of Cancer Prostatic Neoplasms Ovarian Neoplasms Lung Neoplasms Colonic Neoplasms Stomach Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Gene Expression Regulation, Neoplastic Cancer Vaccines Neoplasm Proteins Dose-Response Relationship, Drug Mutation Survival Analysis Drug Screening Assays, Antitumor Uterine Cervical Neoplasms Drug Resistance, Neoplasm Survival Rate Genetic Predisposition to Disease Plant Extracts Molecular Structure Prognosis Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies Xenograft Model Antitumor Assays Cell Survival Carcinoma Gene Expression Profiling RNA, Messenger Carcinoma, Squamous Cell Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Risk National Cancer Institute (U.S.)Disease Progression Receptors, Estrogen Prospective Studies Colorectal Neoplasms Sulfur Compounds Drug Evaluation, Preclinical Registries Volatile Organic Compounds United States Risk Assessment Blotting, Western Inhibitory Concentration 50 Tumor Markers, Biological Structure-Activity Relationship Neoplasm Staging Neoplasm Transplantation Receptor, erbB-2 Antineoplastic Agents, Phytogenic Survivors Combined Modality Therapy Rectal Neoplasms RNA, Small Interfering Neoplasm Recurrence, Local Cell Transformation, Neoplastic Disease-Free Survival DNA, Neoplasm Odds Ratio Prostate-Specific Antigen Sensitivity and Specificity Tumor Suppressor Protein p53 Molecular Sequence Data Endometrial Neoplasms Age Factors Cell Division Transplantation, Heterologous Smoking DNA Methylation Tamoxifen Anticarcinogenic Agents Chemotherapy, Adjuvant Cisplatin Enzyme Inhibitors Genotype Fluorouracil Down-Regulation Clinical Trials as Topic Treatment Outcome Models, Biological Esophageal Neoplasms Risk Factors

No FAQ available that match "compounds to treat cancer"